In June and July 2024, 19 imported cases of Oropouche virus disease were reported for the first time in EU countries: Spain (12), Italy (5), and Germany (2). Eighteen of the cases had a travel history to Cuba and one to Brazil. Oropouche virus disease is a zoonotic disease caused by the...

As stated in Article 8 of the Regulation (EU) 2022/2371 on Serious Cross-Border Threats to Health (SCBTH), ECDC has the responsibility, in coordination with relevant Union agencies and bodies, to conduct Public Health Emergency Preparedness Assessments (PHEPA) of all 30 European Union and...

If the AIDS epidemic is to be brought to end by 2030, it is crucial to combat HIV-related stigma and discrimination in healthcare settings, as per United Nations (UN) Sustainable Development Goal 3 Target 3.3 [1] and the Paris Declaration [2]. The UNAIDS target related to stigma and...

The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease...

The European Centre for Disease Prevention and Control (ECDC) has developed a monitoring system for hepatitis B and C to support countries in the European Union (EU) and European Economic Area (EEA) in monitoring responses to their epidemics of hepatitis B and C. The monitoring system is closely...

In 2021, the Joint United Nations Programme on HIV/AIDS (UNAIDS) updated the HIV targets for 2025 as part of the global strategy to end AIDS by 2030. The updated targets are for 95% of all people living with HIV (PLHIV) to be diagnosed, 95% of those diagnosed to be on antiretroviral treatment...

In 2022-2023, 28 EU/EEA countries and three Western Balkan countries (Kosovo, Montenegro and Serbia) participated in the third ECDC point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals. Data from a total of 1 623...

This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is based on data collected between February and August 2023, for the period 2022. If countries do not have data for 2022, the latest available data is reported. This report is based on data...

The year 2022 marks the second year of recovery in the number of people diagnosed with TB and treated after an unprecedented drop in 2020 due to COVID-19-related disruptions. This has reversed the damaging impact of the pandemic on the number of people falling ill with TB. At the same time, the...

In 2021 and 2022, a survey was developed to assess the impact of COVID-19 on HIV service delivery and monitoring capacity in Europe and Central Asia. Countries were asked whether COVID-19 had an impact on several HIV-specific and non-HIV specific services compared to pre-COVID levels. Although...